Products

Anti-APP Therapeutic Antibody (2B12) (TAB-0848CLV)

The anti-APP antibody specifically binds amyloid precursor protein from which the β-amyloid is cleaved. By binding the APP and therefore reducing the accumulation or the release of β-amyloid, the antibody can be used in the treatment of conditions related with elevated levels of β-amyloid, such as Alzheimer's Disease.      

Specifications
Immunogen
Ka (spanning the β-secretase cleavage site in human APP)
Host
Mouse
Specificity
Human
Clone
2B12
Related Disease
Alzheimer's Disease
Target
Alternative Names
APP; Amyloid Beta; amyloid beta (A4) precursor protein
Entrez Gene ID
351
UniProt ID
P05067

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved